Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-26-001917
Filing Date
2026-03-17
Accepted
2026-03-17 15:49:54
Documents
64
Period of Report
2026-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JAN 2026 pharmacyte_i10q-013126.htm   iXBRL 10-Q 1398332
2 CERTIFICATION pharmacyte_ex3101.htm EX-31.1 9173
3 CERTIFICATION pharmacyte_ex3102.htm EX-31.2 9167
4 CERTIFICATION pharmacyte_ex3201.htm EX-32.1 4490
5 CERTIFICATION pharmacyte_ex3202.htm EX-32.2 4539
  Complete submission text file 0001683168-26-001917.txt   6763572

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pmcb-20260131.xsd EX-101.SCH 57011
7 XBRL CALCULATION FILE pmcb-20260131_cal.xml EX-101.CAL 57517
8 XBRL DEFINITION FILE pmcb-20260131_def.xml EX-101.DEF 279760
9 XBRL LABEL FILE pmcb-20260131_lab.xml EX-101.LAB 410502
10 XBRL PRESENTATION FILE pmcb-20260131_pre.xml EX-101.PRE 384747
68 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_i10q-013126_htm.xml XML 939525
Mailing Address 3960 HOWARD HUGHES PARKWAY SUITE 500 LAS VEGAS NV 89169
Business Address 3960 HOWARD HUGHES PARKWAY SUITE 500 LAS VEGAS NV 89169 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-40699 | Film No.: 26761524
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)